Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena E Balashova

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Recent Patents on Biotechnology|December 2, 2016
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer VaccinesPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|February 26, 2015
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)Petr G Lokhov, Elena E Balashova
Journal of Immunology Research|October 27, 2016
Allogeneic Antigen Composition for Preparing Universal Cancer VaccinesPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|February 28, 2013
Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitroPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|April 11, 2013
Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cellsPetr G Lokhov, Elena E Balashova
Journal of Cancer|December 15, 2010
Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigensPetr G Lokhov, Elena E Balashova
Cancers|March 6, 2021
Antigenic Essence: Upgrade of Cellular Cancer VaccinesPetr G Lokhov, Elena E Balashova
International Journal of Molecular Sciences|April 23, 2022
Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen CompositionsPetr G Lokhov, Steven Lichtenberg, Elena E Balashova
Molecular & Cellular Proteomics : MCP|November 15, 2011
Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrenceElena E Balashova, Maxim I Dashtiev, Petr G Lokhov
Biotech (Basel (Switzerland))|July 13, 2022
Metabolomics Community in Russia: History of Development, Key Participants, and ResultsElena E Balashova, Dmitry L Maslov, Oxana P Trifonova
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Recent Patents on Biotechnology|December 2, 2016
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer VaccinesPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|February 26, 2015
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)Petr G Lokhov, Elena E Balashova
Journal of Immunology Research|October 27, 2016
Allogeneic Antigen Composition for Preparing Universal Cancer VaccinesPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|February 28, 2013
Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitroPetr G Lokhov, Elena E Balashova
Human Vaccines & Immunotherapeutics|April 11, 2013
Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cellsPetr G Lokhov, Elena E Balashova
Journal of Cancer|December 15, 2010
Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigensPetr G Lokhov, Elena E Balashova
Cancers|March 6, 2021
Antigenic Essence: Upgrade of Cellular Cancer VaccinesPetr G Lokhov, Elena E Balashova
International Journal of Molecular Sciences|April 23, 2022
Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen CompositionsPetr G Lokhov, Steven Lichtenberg, Elena E Balashova
Molecular & Cellular Proteomics : MCP|November 15, 2011
Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrenceElena E Balashova, Maxim I Dashtiev, Petr G Lokhov
Biotech (Basel (Switzerland))|July 13, 2022
Metabolomics Community in Russia: History of Development, Key Participants, and ResultsElena E Balashova, Dmitry L Maslov, Oxana P Trifonova
Pageof 4